This Solicitation opportunity from Department Of Health And Human Services was posted on June 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Semiautomatic Aerosol Propellant Filler
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The U.S. Food and Drug Administration, through its Center for Drug Evaluation and Research and Office of Testing and Research, is seeking a semiautomatic aerosol propellant filler system for use in research on pressurized metered-dose inhalers utilizing both traditional and next-generation propellants. The requirement is for a complete system, including the base unit, a 2002/100 crimper assembly, a crimp height measuring gauge, a propellant pump package with filters and spare parts, as well as comprehensive support services such as factory acceptance documentation, validation support, installation, operator training, and a one-year warranty covering onsite repairs. The system must meet strict material standards, with all product-contact components constructed from AISI 316L stainless steel and accompanied by EN 10204-3.1 material certifications. The equipment must feature a two-hand safety protection guard and be delivered to a specified laboratory at the FDA facility in Silver Spring, Maryland. Delivery and installation must be completed within 90 calendar days of award, with training finalized within five business days after installation, and full acceptance by the Government must occur within 30 working days following installation and operational testing. The procurement follows FAR Part 12 and Part 13 procedures under an LPTA source selection process, meaning award will go to the technically acceptable offeror with the lowest evaluated price, provided past performance is acceptable or neutral. All quotations must be submitted electronically by June 22, 2026, and must include a completed Buy American Act Compliance Certification, SAM registration status, Unique Entity Identifier, detailed compliance matrix, product literature, country of origin disclosures, Trade Agreements Act compliance, and past performance references. The offeror must hold pricing firm for 120 days after submission and comply with all contractual clauses including those addressing whistleblower rights, internal confidentiality prohibitions, electronic invoicing via the Treasury’s IPP system, information and communication technology accessibility, key personnel, and anti-lobbying requirements. Invoices must be submitted electronically and include a detailed invoice log addendum, certification of service delivery, and supporting documentation for any labor or cost-reimbursement line items.
General Info
Agency
NAICS
Place of Performance
Silver Spring, MD, 20993, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Semiautomatic Aerosol Propellant Filler for pMDI Two-Stage Formulation
Brand Name or Equal
This is a Request for Quotation (RFQ) for commercial products prepared in accordance with FAR Part 12 and FAR Part 13 procedures utilizing the FAR Revolutionary FAR Overhaul clauses and provisions available at Acquisition.gov.
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Testing and Research (OTR), requires the purchase, delivery, installation, validation support, training, and warranty of a Semiautomatic Aerosol Propellant Filler for pMDI Two-Stage Formulation. The requirement supports FDA research in advanced pharmaceutical manufacturing and inhalation drug delivery systems.
Please refer to the following attachments for all the pertinent details of this requirement
Attachment I Statement of Work (SOW)
Attachment II Pricing Schedule
Attachment III Past Performance Reference Form
Attachment IV SF-18 Request for Quotations
Attachment V Brand Name or Equal Compliance Matrix
Attachment VI Buy American Certificate
Attachment VII Solicitation Document
Submit all questions in writing via email to Michele.Jackson@fda.hhs.gov no later than: June 15, 2026, at 9:00 AM Eastern Time
Questions received after this date may not receive a response.
Submit quotations electronically to Michele.Jackson@fda.hhs.gov no later than June 22, 2026, at 11:00 AM Eastern Time
Include in the Subject Line: [Company Name] – 75F40126Q00231/CDER-2026-133243 Quote
More opportunities from Department Of Health And Human Services → Food And Drug Administration
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
